Dr. Wolfgang Rehmann
Dr. Wolfgang Rehmann

Dr. Wolfgang Rehmann

特邀律师

+49 89 21038 0
Call me
奖励

Lexology Index 2025

Recommended Lawyer: Healthcare & Life Sciences - Regulatory

Wolfgang is one of the leading experts on pharmaceutical law and medical device law in Germany. With his many years of industry knowledge and international experience, he represents small and medium-sized companies from the pharmaceutical and medical device industries, as well as global players.

 

In the Life Sciences team of Taylor Wessing, Wolfgang develops solutions for complex, strategic challenges facing this sector. In addition, he represents his clients' interests before authorities and in court, including in European court proceedings in Luxembourg. Wolfgang is also a lecturer at the University of Marburg.

专长

执业领域和服务团队

专利与创新
生命科学监管咨询
法国德国团队

行业

酒店与休闲
生物技术
化妆品、食品营养与补品

CV

Since 1987 Partner, Taylor Wessing
1983 – 1987 Associate, Zimmermann Hohelohe Sommer Rojahn
1982 – 1983 In-house Counsel, Fraunhofer Gesellschaft

职业发展

Since 1987 Partner, Taylor Wessing
1983 – 1987 Associate, Zimmermann Hohelohe Sommer Rojahn
1982 – 1983 In-house Counsel, Fraunhofer Gesellschaft

教育

1983 Admitted as a lawyer, Munich
1983 Doctoral degree, Dr. iur. utr., Ludwig-Maximilians-Universität of Würzburg
1982 Second state examination, Bayern

Publications

Kommentar zur Verordnung über Medizinprodukte; Co-Author: Dr. Susanne A. Wagner; Beck Verlag; 2023 

AMG Kommentar Beck Verlag

MPG Kommentar co-author Beck Verlag

Arzthaftungsprozess, Luchterhand co-author

Arzneimittel und Recht, regular publications

PharmaRecht, regular publications

Medzinprodukte Journal, regular publications

Medizinproduktrecht, regular publications

会员资格和附属关系

GRUR
LIDC

语言

English French

奖励

Lexology Index 2025

Featured

Lexology Index 2025

The Best Lawyers™ in Germany 2025

Chambers Germany 2025

Experience

Pharmaceutical portfolio divestments across 24 EU jurisdictions

Teva Pharmaceuticals Europe BV on its divestments of portfolios of generic pharmaceutical products (approximately 260 medicinal products) in 24 EU jurisdictions to multiple purchasers, in addition to advising Teva on the divestment of certain parts of its business. The divestments were a condition enforced by the European Commission to approve Teva's USD40.5 billion acquisition of Allergan plc’s global generics and have been run as a competitive auction process, resulting in five asset sales.

Evelyne Friedel
Dr. Wolfgang Rehmann
Radovan Pala, Ph.D., LL.M.

Provision of pan-European pharma and patent advice

A leading international healthcare company on provision of European-wide advice across a variety of legal areas including pharmaceutical law and patents.

Dr. Wim Maas
Dr. Wolfgang Rehmann

最新新闻和观点

View Wolfgang's insights
点击此处了解更多
专利与创新

JUVE Awards 2023: Taylor Wessing named "Law Firm of the Year for IP”

2023年10月27日

作者

Glass.Mapper.Sc.Fields.Image?.Alt
德国

Chambers Europe 2022 recommends 28 Taylor Wessing lawyers from 21 Practice Areas whilst Data Protection is listed for the first time

2022年3月21日

作者

点击此处了解更多
Glass.Mapper.Sc.Fields.Image?.Alt
公司/并购与资本市场

Taylor Wessing advises Hauck & Aufhäuser and mBank on voluntary public exchange offer of Vita 34 AG to the shareholders of Polish PBKM

Taylor Wessing advises Hauck & Aufhäuser and mBank on voluntary public exchange offer of Vita 34 AG to the shareholders of Polish PBKM

2021年11月29日

作者

点击此处了解更多
View Wolfgang's insights

Related news & insights

专利与创新

Preliminary injunctions in Poland

2025年11月5日
Briefing

作者 Bartosz Świdrak 以及 Karolina Ciąglewicz

点击此处了解更多
酒店与休闲

Biotechnology as a security issue: Why dual-use control and adaptive regulation are crucial for national sustainability

2025年11月3日
Quick read

作者 Dr. Niclas von Woedtke, MBA (Kellogg/ WHU)

点击此处了解更多
专利与创新

Preliminary injunctions in Belgium

2025年10月29日
Briefing

作者

点击此处了解更多
ESG
环境、社会和公司治理 (ESG)

Sustainability claim? Beware of enforcement by the ACM

2025年10月28日
Briefing

作者

点击此处了解更多
专利与创新

Preliminary injunctions in France

2025年10月22日
Briefing

作者

点击此处了解更多
酒店与休闲

Advertising skinny jabs – regulators react

2025年10月15日
Quick read

作者 Alison Dennis 以及 Alice Matthews

点击此处了解更多
专利与创新

Preliminary injunctions in Austria

2025年10月15日
Briefing

作者

点击此处了解更多
酒店与休闲

Reform of the Veterinary Medicines Act

2025年10月13日
Briefing

作者 Dr. Daniel Tietjen 以及 Daniel Dietrich

点击此处了解更多
专利与创新

Preliminary injunctions in Ireland

2025年10月8日
Briefing

作者 Hannah Garvey 以及 Eoin Martyn

点击此处了解更多
专利与创新

Once daily, twice defeated in Ireland

2025年10月6日
Quick read

作者 Hannah Garvey 以及 Eoin Martyn

点击此处了解更多
View all insights

相关人员

德国
Global

Daniel Dietrich

律师

慕尼黑
+49 89 21038 0
查看个人资料

Stefanie Engmann, LL.M. (Northwestern)

高级律师

慕尼黑
+49 89 21038 0
查看个人资料

Dr. Daniel Tietjen

合伙人

慕尼黑
+49 89 21038-0
查看个人资料

Dr. Gisbert Hohagen, Lic. en droit (Paris II/ Assas)

合伙人

慕尼黑
+49 89 21038 261
查看个人资料

Dr. Jacob Carl

律师

慕尼黑
+49 89 21038 0
查看个人资料

Leoni König

律师

慕尼黑
+49 89 21038 0
查看个人资料

Marco Berlage

高级律师

杜塞尔多夫
+49 211 8387 0
查看个人资料

Irina Rebin

授薪合伙人

慕尼黑
+49 89 21038 0
查看个人资料
Nora E. Wessendorf

Dr. Nora E. Wessendorf, LL.M. (Washington)

授薪合伙人

杜塞尔多夫
硅谷
+49 211 8387 0
查看个人资料

Ennio Schwind, LL.M. Eur.

律师

慕尼黑
+49 89 21038 0
查看个人资料
Full team

Dr. Jacob Carl

律师

慕尼黑
+49 89 21038 0
查看个人资料

Irina Rebin

授薪合伙人

慕尼黑
+49 89 21038 0
查看个人资料
Clémence de Marassé-Enouf

Clémence de Marassé-Enouf

律师

巴黎
+33 1 72 74 03 33
查看个人资料

Julie Chiu

高级法律顾问

伦敦
+44 20 7300 7000
查看个人资料
Andrew Payne

Andrew Payne

合伙人

伦敦
+44 207 300 7145
查看个人资料
Paul England

Dr Paul England

Senior Counsel – Knowledge

伦敦
+44 20 7300 7000
查看个人资料
/Taylor Wessing/Images/People/Profiles/France/Millot-Louise/Millot-Louise-wit

Louise Millot

律师

巴黎
+33 1 72 74 03 33
查看个人资料
Paula Terzini Leite

Paula Terzini Leite

UPC 法务官

埃因霍温
+31 88 02 43 282
查看个人资料
Benjamin Znaty

Benjamin Znaty

Counsel

巴黎
+33 172 74 03 33
查看个人资料

Rebecca Limer

高级律师

伦敦
+44 20 7300 7000
查看个人资料
Full team

与我会面：

查看所有活动

© Taylor Wessing